Next Tuesday my sister returned to the Capitol to have her leg pressed. A week before, she was operated on as possibly having “bukol” carcinoma. Fortunately, the biopsy dismissed the fear. The “bukol” seems to be from her sensitive skin reaction to a wart or mosquito bite. After a week of waiting for the sutures to heal, the suture was removed, and WOW! He looked at the rotten area of the seamstress. Then the doctor prescribed him this medicine to reduce the inflammation around the area. I found it curious and read all the information on the papers, I understood every detail, and I made this article for those who want to know what about all the drugs. my skin after all was more sensitive than that. 😛
Company
Elica 0.1% products are manufactured by Schering Canada Inc. at Pointe Claire, Quebec, Canada. The products were patented in 1987/1988 by Schering International Plow. In the Philippines, products by Schering-Plow Corporation (importer) held their office at Torsedillas St., Salcedo Village, Makati. (According to the box, the office is at 12FSan Miguel Center, Saint Francis St., Ortigas. Center, Mandaluyong.)
Entering Active
Elica 0.1% products are intended for external use only and are recommended to be stored at room temperature, specifically no more than 30 degrees Celsius. They basically act against corticosteroid-responsive dermatoses, or skin diseases involving corticosteroids. Examples of these skin diseases are Psoriasis and Atopic Dermatitis. Psoriasis is characterized by uneven red and white scales. Atopic dermatitis, on the other hand, is a symptomatic inflammation that appears to be hereditary. Generally, these skin diseases manifest on the human skin as inflammation and itching. These manifestations are then treated by Elica 0.1% products by the active ingredient, Mometasone Furoate – an anti-inflammatory and anti-pruritic synthetic corticosteroid. It is present in Elica 0.1% products in the proportion of 1 mg in 1 g of formulas, hence the percentage (0.1%). Most often, Elica 0.1% products are used simultaneously with anti-fungal or anti-bacterial substances or with other corticosteroids. This happens because most dermatoses present skin infection. In simultaneous cases treatment of yeast infection and corticosteroid-responsive dermatosis shows adverse changes, the infection is treated first. inflammation and/or itching. In my sister’s case, the medication was prescribed after it was discovered that my sister presented with inflammation in the area where she was working, that is long after she took the anti-biotic medication.
Formulas
Elica 0.1% products are available in various forms: cream, ointment and ointment. All the formulas are composed of an active formula (Mometasone Furoate), purified and phosphoric acid (to adjust the PH Herennius). Apart from these, the lotion is made up of Propylene Glycol, Isopropyl Alcohol, Hydroxypropyl Cellulose, Sodium Phosphate and Monobasic Monohydrate. The cream and ointment are composed of Propylene Glycol Stearate, White Petrolatum, White Wax, and Hexylene Glycol; while the cream has added, such as Stearyl Alcohol, Cetereth-20, Titanium Dioxide, Aluminum Starch and Octenylsuccinate. The cream and perfume are packed in 5 g tubes, while the coating is in 30 mL bottles. All substances are applied to skin once a day – a thin film of cream and ointment, and a few drops to smear. (I wonder this more: How is my sister’s prescribed dose twice every two weeks? She has been using the cream for four days now and has not shown any signs of adverse reactions yet. The dosage may be changed by the prescribing physician from time to time.) Overdosage can be cured by by treating electrolyte imbalance and by exercising in slow drug removal. Abrupt drug withdrawal probably causes user withdrawal symptoms, although information about withdrawal symptoms is not provided in the information sheet.
Administration & Caution
Dual administration of Elica 0.1% products: topical and systemic. Both methods of administration facilitate systemic absorption, that is, the body system nevertheless absorbs drug whatever form of administration is used, leading to adrenal suppression (in which hormones are stopped from being secreted by the adrenal glands). Adrenal suppression can in turn lead to stunted growth and/or Cushing syndrome – characteristic weakness and pain of muscular obesity due to excessive corticosteroid use. Extensive treatment of the body surface, use of occlusive technique in the application (sandwich medicine between the incision), and long-term use make the body very susceptible to these damages. Pediatric patients (children), in particular, are more susceptible than adult patients because of the ratio of their skin surface to body weight “https://e-info.vn/tag/” /a> is older than adults. In addition, the drug can penetrate through systemic absorption through breast milk. Although the information sheet states that the secret medicine together with the milk breast-milk is harmful, it should be advised that it is an option for nursing and breastfeeding mothers. they must have whether they are nursing or not nursing and taking medicine. Furthermore, safe use by pregnant mothers has not yet been established. Because of this, it is recommended that doctors prescribe the drug to pregnant mothers, unless there is a potential benefit to the mother, a greater risk to the potential fetus.
Adverse reactions
Adverse reviews on the use of Elica 0.1% of products are reported very rarely or infrequently. These include itching, skin atrophy (flaking), paresthesia, itching, burning, folliculitis (inflammation ; skin maceration, secondary infection, stretch marks and obvious milestones. These adverse reactions are curiously related to inflammation and itching, the very manifestations that the active ingredient is intended to combat. Perhaps, homeostasis lies in corticosteroids between too much or too little hormone.
Limitation
Given the precautions and adverse reactions from drug use; and the risk of potential abuse and exploitation by children, pregnant mothers and lactating women; Therefore, the products elica 0.1% are covered by food, drugs, technology and cosmetics Act. A prescription must therefore be made before the use of the prescription.
